Literature DB >> 3919092

The murine IL 2 receptor. III. Cellular requirements for the induction of IL 2 receptor expression on T cell subpopulations.

T R Malek, J A Schmidt, E M Shevach.   

Abstract

The accessory cell requirements for the induction of the IL 2 receptor by the lectin Con A on murine T cell subsets were directly assayed with anti-IL 2 receptor monoclonal antibodies. Substantial levels of IL 2 receptor expression were induced on T lymphocytes of the MHC class I-restricted, suppressor/cytotoxic phenotype (L3T4-, Ly-2+) in the presence and absence of accessory cells. In contrast, high levels of IL 2 receptor expression could only be induced on T cells of the MHC class II-restricted, helper/inducer phenotype (L3T4+, LY-2-) in the presence, but not in the absence, of accessory cells. Ia- cells such as the P388D1 macrophage line or cultured fibroblasts (DAP X 3) were as efficient as the Ia+ B cell hybridoma LB in providing accessory cell function for the L3T4+, Ly-2- subset. PMA, but not purified human IL 1, could substitute for accessory cells for both IL 2 receptor expression and IL 2 secretion by the L3T4+, Ly-2- subset. These data suggest that IL 2 receptor induction on the L3T4+, Ly-2- subset is complex, possibly requiring a T cell-accessory cell interaction, whereas the lectin may directly trigger IL 2 receptor expression on L3T4-, Ly-2+ T cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919092

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Major histocompatibility complex class II- fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses.

Authors:  A Elbe-Bürger; A M Mommaas; E E Prieschl; E Fiebiger; T Baumruker; G Stingl
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

2.  Costimulatory signal provided by a B-lymphoblastoid cell line and its Ia-negative variant.

Authors:  H Reiser; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.

Authors:  C A Ottaway
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

4.  Production and characterization of cloned T-cell hybridomas that are responsive to Rickettsia conorii antigens.

Authors:  D L Jarboe; C S Eisemann; T R Jerrells
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

Review 5.  T cell receptors of autoimmune mice: functional and molecular analysis of novel T cell subsets in C3H-gld/gld mice.

Authors:  K Yui; Y Hashimoto; M I Greene
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

6.  Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression.

Authors:  P M Kaye
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

7.  Unresponsiveness to Con A in spleen cell cultures of M. lepraemurium-infected mice is dependent on a defective expression of high-affinity IL-2 receptors rather than on a lack of IL-2 production.

Authors:  R Turcotte; S Lemieux
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

Review 8.  Regulation of lymphocyte growth by antagonists of interleukin-2 or its cellular receptor.

Authors:  G N Gaulton; J F Markmann
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

9.  Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells.

Authors:  Z Razi-Wolf; G J Freeman; F Galvin; B Benacerraf; L Nadler; H Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  Accumulation of regulatory T cells in local draining lymph nodes of the lung correlates with spontaneous resolution of chronic asthma in a murine model.

Authors:  William F Carson; Linda A Guernsey; Anurag Singh; Anthony T Vella; Craig M Schramm; Roger S Thrall
Journal:  Int Arch Allergy Immunol       Date:  2007-10-04       Impact factor: 2.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.